IOVS Journal of Neuroscience
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2008;49:1660-1664.)
© 2008 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.07-1094

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roomets, E.
Right arrow Articles by Tyni, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roomets, E.
Right arrow Articles by Tyni, T.

Carnitine Palmitoyltransferase I and Acyl-CoA Dehydrogenase 9 in Retina: Insights of Retinopathy in Mitochondrial Trifunctional Protein Defects

Eva Roomets,1,2 Tero Kivelä,3 and Tiina Tyni1

1From the Department of Pediatric Neurology, Hospital for Children and Adolescents, and the 3Department of Ophthalmology, Helsinki University Central Hospital, Helsinki, Finland; and the 2University of Helsinki, Helsinki Biomedical Graduate School, Helsinki, Finland.

PURPOSE. Progressive pigment chorioretinopathy is a major long-term complication of mitochondrial trifunctional protein (MTP) defects, disorders of mitochondrial fatty acid β-oxidation. To better understand the pathogenesis of the retinopathy component, the authors studied expression of the main regulatory protein of the β-oxidation pathway, carnitine palmitoyltransferase (CPT) 1, and acyl-CoA dehydrogenase (ACAD) 9 in retinal sections and cultured cells.

METHODS. Immunoblotting was performed with polyclonal antibodies to ACAD9 and the three isoforms of CPT1. In quantitative real-time PCR (QRT-PCR), predesigned gene-specific probes and primer sets for human CPT1 isoforms were used. In situ hybridization (ISH) and immunohistochemistry was performed on formalin-fixed, paraffin-embedded sections of the rat and human eye.

RESULTS. The predominant CPT1 mRNA types detected by QRT-PCR in cultured human retinal pigment epithelial cells were of the liver (CPT1A) and brain (CPT1C) isotypes. CPT1A and ACAD9 protein expression was found in cultured human and rat RPE and rat neural retinal precursor cells. ISH of rat retinal sections showed CPT1A and CPT1C expression in the retinal pigment epithelium (RPE), the inner nuclear layer, and the ganglion cell layer. CPT1A expression was also detected in the Müller cell microvilli, and CPT1C expression was detected in the photoreceptor inner segments. ACAD9 immunolabeling was detected in rat and human RPE, human photoreceptor inner segments, and ganglion cell layer.

CONCLUSIONS. These findings imply that the mitochondrial fatty acid β-oxidation pathway probably is active in metabolism of the RPE and certain neuroretinal cell types. Accumulation of 3-hydroxylated intermediates of long-chain fatty acids may contribute to the pathogenesis of retinopathy in MTP deficiencies.








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Association for Research in Vision and Ophthalmology